Mirel 18mg Powder for Injection
By Mirel
Rx
1 Powder for Injection in a Packet

Composition
Reteplase(18mg)

Manufacturer - Reliance Life Sciences
Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701

Expires on or after
April, 2026

liver
When considering Mirel 18mg Powder for Injection, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. Please consult your doctor before starting treatment. It is not advised to use Mirel 18mg Powder for Injection in individuals with severe kidney disease.

kidney
Mirel 18mg Powder for Injection should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Avoid use in severe kidney disease. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Mirel 18mg Powder for Injection.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Mirel 18mg Powder for Injection.

pregnancy
Mirel 18mg Powder for Injection may not be safe to use during pregnancy. Animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Mirel 18mg Powder for Injection is considered safe during breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | Carboxylic Acid Derivative |
Therapeutic Class | - |
Action Class | Plasminogen Activators- Thrombolytics |
₹21931
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025